-+ 0.00%
-+ 0.00%
-+ 0.00%

iRadimed Narrows FY2026 GAAP EPS Guidance from $1.90-$2.05 to $1.90-$1.94 vs $1.94 Est

Benzinga·10/30/2026 12:33:44
Listen to the news
iRadimed (NASDAQ:IRMD) narrows FY2026 GAAP EPS guidance from $1.90-$2.05 to $1.90-$1.94 vs $1.94 analyst estimate..